Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
2,351,108
-
Total 13F shares
-
115,174
-
Share change
-
+115,174
-
Total reported value
-
$330,990
-
Price per share
-
$2.88
-
Number of holders
-
10
-
Value change
-
+$330,990
-
Number of buys
-
10
Institutional Holders of Processa Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PCSA) as of Q4 2025
As of 31 Dec 2025,
Processa Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PCSA) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
115,174 shares.
The largest 10 holders included
JANE STREET GROUP, LLC, VANGUARD GROUP INC, HRT FINANCIAL LP, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Stonepine Capital Management, LLC, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, JONES FINANCIAL COMPANIES LLLP, and WELLS FARGO & COMPANY/MN.
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.